These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 2852235

  • 21. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
    Buus NH, Jørgensen CG, Mulvany MJ, Sørensen KE.
    Blood Press; 2007; 16(2):106-13. PubMed ID: 17612909
    [Abstract] [Full Text] [Related]

  • 22. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

  • 23. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ, Lees KR, Reid JL.
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [Abstract] [Full Text] [Related]

  • 24. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [Abstract] [Full Text] [Related]

  • 25. Effect of perindopril in pacing-induced canine models of acute and chronic heart failure.
    Ogilvie RI, Zborowska-Sluis D.
    Can J Cardiol; 1995 Nov; 11(10):934-40. PubMed ID: 7489534
    [Abstract] [Full Text] [Related]

  • 26. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension.
    Asmar RG, Pannier B, Santoni JP, Laurent S, London GM, Levy BI, Safar ME.
    Circulation; 1988 Oct; 78(4):941-50. PubMed ID: 2971473
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo].
    Bounhoure JP, Bottineau G, Lechat P, Garnham J, Lapeyre G.
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():73-8. PubMed ID: 2505716
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Regulation of circulation in congestive heart failure.
    Solti F, Iskum N, Váradi A, Acsády G.
    Z Kardiol; 1990 Apr; 79(4):308-11. PubMed ID: 2356645
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.
    Newby DE, Goodfield NE, Flapan AD, Boon NA, Fox KA, Webb DJ.
    Heart; 1998 Aug; 80(2):134-40. PubMed ID: 9813557
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.